Steroid pills with skin cell transplant for stable vitiligo
Part of Skin clinical trials.
This trial tests whether taking short courses of steroid pills alongside a skin cell transplant procedure helps treat stubborn vitiligo patches on the elbows and knees that have not improved with standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your vitiligo patches are on your elbows or knees and have not improved with usual treatments.
- Your vitiligo has been stable for at least 1 year (no new spots or spreading).
- You have not used creams on the patches for at least 1 month and have not taken pills for vitiligo for at least 3 months before the procedure.
- You are not pregnant, and you do not have high blood pressure, diabetes, or tuberculosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a short course of steroid pills (taken by mouth in a pulse pattern) to a skin-grafting procedure helps prevent a pale ring from forming around the treated spots in people with stable vitiligo. The procedure takes healthy, pigment-making skin cells from one area and applies them to the white patches.
This study tests whether applying a strong steroid cream (betamethasone) with the help of ultrasound waves (phonophoresis) can repigment vitiligo patches. It aims to see if this combination works better than the cream alone.
This trial tests a surgery that uses your own skin cells to treat stable vitiligo patches. It may help when creams or light therapy haven't worked.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
This trial tests a daily pill (upadacitinib) to see if it can improve vitiligo after an initial treatment (NECS). It is for people whose vitiligo is stable and covers a limited area.
This Phase 2 trial tests whether a new drug called D-2570 can help restore skin color in people with non-segmental vitiligo (when white patches appear randomly across the body). The study will track how well the drug works and check if it's safe to use.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.